Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.
about
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic reviewThe endocannabinoid system in normal and pathological brain ageingNarrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disordersThe therapeutic potential of cannabis and cannabinoidsMedical marijuana: clearing away the smokeAdverse effects of medical cannabinoids: a systematic reviewEvidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosisComplementary and Alternative Therapies in Amyotrophic Lateral SclerosisAdverse health effects of marijuana useMultiple sclerosisRole of cannabinoids in multiple sclerosisComplementary and alternative medicine for the treatment of multiple sclerosisPharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.Evolution of multiple sclerosis spasticity-associated symptoms: latest data.New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids.Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.The endocannabinoid system as a target for the treatment of neurodegenerative disease.The pharmacologic and clinical effects of medical cannabis.Therapeutic potential of cannabinoid medicines.Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomitingSummary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.Medical marijuana in neurology.Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).Cannabinoid control of neuroinflammation related to multiple sclerosis.The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.Cannabidiol: a promising drug for neurodegenerative disorders?Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy.Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticityAn observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray.Spasticity, an impairment that is poorly defined and poorly measured.
P2860
Q21261356-CD79A520-11FC-440D-A795-B0F98B83ABD3Q22242668-F1CF8A1C-17E6-46D7-90DB-2C1D09D8D9F4Q22299116-843C973F-1405-42A4-96EF-DE0E16ED39E1Q24600806-0BB6592E-B1C0-44C4-A74A-4A585D79FF43Q24617731-9295B319-69D4-4708-88E1-EB320B770404Q24644380-3649F369-620F-42BC-AC6E-5F3303EFB764Q26770823-0EBB53F9-6B38-40CF-893B-64627A9E5316Q26777929-6FE94D7E-FAAF-4F21-8006-E64762A1AD7BQ26861513-3BCBBCF1-38E6-4475-8F72-B31A95E24C18Q26995437-54AEF89E-55C8-46B4-AA0F-D15F0291FDA1Q28305413-401E4B57-6201-49CA-AF02-0FA917ED104BQ29031018-A6F801AF-63F8-45D4-ABC5-497908D4D2B1Q30250250-D791992E-E7FE-40C3-8270-024009290F4BQ31028236-0A99EEB4-8393-43B0-BF46-6029F982C299Q31144052-338D0CE5-6852-4C24-AC06-D25513C98217Q33715420-53202EE3-448E-49D5-B8C9-B3E763182C1FQ33857586-7A9C6058-E8FD-49DA-A3C6-6AAA5E38C475Q34098196-09D5DDB7-6C5B-45C2-8DB1-22FB747115B0Q34326515-BAB70ABE-75FF-467B-8603-DF532ED7D1E1Q34368715-8C44991A-295A-4994-A239-034D34C6CB93Q34381296-E29C75EB-C91B-4B2C-BD99-9A70C529C6E9Q34411793-29D2825B-C029-4BF0-9574-91EEAEFF89E9Q34417710-9D52C233-2F3B-41B6-B53F-84E264448971Q34449698-C77C0B8D-BBF0-4314-AE1F-799E9F6158E0Q34461976-AE36F8EF-B0CC-497B-894C-FE761F782024Q34583231-27E15F31-D8D4-4322-A179-1A1DE9B4A978Q34589360-649D2F49-DF96-49BC-938A-537807F29EC6Q34612019-1504235A-7B0E-4EBA-B01B-0034F3C03C23Q34631934-E9FE6388-F4B8-4A09-9074-7E4DC58C1B44Q34638273-49DB245C-C133-4A05-9719-2F28F410A056Q34642592-ACED828D-5167-4010-8A9A-E1D8155D49F9Q34948216-20ADEE5A-FEC8-489A-A80F-323EFF684402Q35577414-02E5F833-4F57-4A7F-ABCB-610D8BCC8D66Q35589934-E9AE8CC3-7BA2-4184-BCA6-F71B85B15B49Q35865445-FBF595ED-0B5B-45DB-A2D0-CC53F818F970Q36178329-00B1D302-E4BD-48DC-BB37-3DF714BC46BAQ37038999-4E0F1DA8-C253-4C7B-9730-1A1C598E7988Q37235845-ED716B78-06FF-4022-82E5-CB9032E641E4Q37420740-C01545FB-91AA-45CD-A495-64F99490B2B6Q37496302-5564D2EF-364C-430D-8C51-C88D753064EA
P2860
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Randomized controlled trial of ...... caused by multiple sclerosis.
@ast
Randomized controlled trial of ...... caused by multiple sclerosis.
@en
Randomized controlled trial of ...... caused by multiple sclerosis.
@nl
type
label
Randomized controlled trial of ...... caused by multiple sclerosis.
@ast
Randomized controlled trial of ...... caused by multiple sclerosis.
@en
Randomized controlled trial of ...... caused by multiple sclerosis.
@nl
prefLabel
Randomized controlled trial of ...... caused by multiple sclerosis.
@ast
Randomized controlled trial of ...... caused by multiple sclerosis.
@en
Randomized controlled trial of ...... caused by multiple sclerosis.
@nl
P2093
P1476
Randomized controlled trial of ...... caused by multiple sclerosis.
@en
P2093
I K Mutiboko
S Ratcliffe
Sativex Spasticity in MS Study Group
P304
P356
10.1111/J.1468-1331.2006.01639.X
P577
2007-03-01T00:00:00Z